IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Overview Fund Activity
Delisted

IDXG was delisted on the 24th of February, 2021.

Back to rankings

23 hedge funds and large institutions have $9.16M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AA
Ancora Advisors
Ohio
+$433K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$78K
3
VKH
Virtu KCG Holdings
New York
+$17K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.73K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$1.29K

Top Sellers

1
PHS
Pekin Hardy Strauss
Illinois
-$119K
2
BFA
BlackRock Fund Advisors
California
-$43K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27.2K
4
UBS Group
UBS Group
Switzerland
-$5K
5
HA
Heartland Advisors
Wisconsin
-$3.58K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– -$1K -4 Closed
1
2